Lithium: Neurotransmission and Cellular Mechanism Pathways Underlying Neuroprogression in Bipolar Disorder-Reference-Cited by-同舟云学术

Lithium: Neurotransmission and Cellular Mechanism Pathways Underlying Neuroprogression in Bipolar Disorder

Published:2016-11-26 Issue: Volume: Page:55-75
ISSN:
Container-title:The Science and Practice of Lithium Therapy
language:
Short-container-title:

Author:

Malhi Gin S.,Outhred Tim,Das Pritha

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-45923-3_3

Reference143 articles.

1. Adler CM, Levine AD, Delbello MP et al (2005) Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry 58:151–157

2. Ahluwalia P, Grewaal DS, Singhal RL (1981) Brain gabaergic and dopaminergic systems following lithium treatment and withdrawal. Prog Neuropsychopharmacol 5:527–530. doi: 10.1016/0364-7722(81)90040-0

3. Alda M (2015) Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics. Mol Psychiatry 20:661–670. doi: 10.1038/mp.2015.4

4. Andreazza AC, Kapczinski F, Kauer-Sant’Anna M et al (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci 34:263–271

5. Bearden CE, Thompson PM, Dalwani M et al (2007) Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry 62:7–16. doi: 10.1016/j.biopsych.2006.10.027

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the pivotal molecular mechanisms, therapeutic and neuroprotective effects of lithium in traumatic brain injury;Brain and Behavior;2024-06

2. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders;Australian & New Zealand Journal of Psychiatry;2020-12-22

3. Recommendations in International Clinical Practice Guidelines for Lithium Therapy of Bipolar Disorder;The Science and Practice of Lithium Therapy;2016-11-26